Cumberland Pharmaceuticals (CPIX) EBIAT (2016 - 2025)
Historic EBIAT for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.
- Cumberland Pharmaceuticals' EBIAT fell 2622.69% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 6937.55%. This contributed to the annual value of -$6.5 million for FY2024, which is 235.36% down from last year.
- Per Cumberland Pharmaceuticals' latest filing, its EBIAT stood at -$1.9 million for Q3 2025, which was down 2622.69% from -$740740.0 recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' EBIAT registered a high of $1.3 million during Q1 2025, and its lowest value of -$6.3 million during Q4 2023.
- Over the past 5 years, Cumberland Pharmaceuticals' median EBIAT value was -$1.4 million (recorded in 2022), while the average stood at -$1.3 million.
- Per our database at Business Quant, Cumberland Pharmaceuticals' EBIAT surged by 17316.29% in 2021 and then plummeted by 111270.81% in 2024.
- Cumberland Pharmaceuticals' EBIAT (Quarter) stood at -$4.4 million in 2021, then skyrocketed by 43.94% to -$2.5 million in 2022, then crashed by 156.21% to -$6.3 million in 2023, then skyrocketed by 69.79% to -$1.9 million in 2024, then dropped by 2.38% to -$1.9 million in 2025.
- Its last three reported values are -$1.9 million in Q3 2025, -$740740.0 for Q2 2025, and $1.3 million during Q1 2025.